No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 700-705

  Bergen, Sarah E ^a,b   Fanous, Ayman H ^a,c,d,e   Kuo, Po Hsiu ^f   Wormley, Brandon K ^a,c   O'Neill, F Anthony ^g   Walsh, Dermot ^h   Riley, Brien P ^a,b,c   Kendler, Kenneth S ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^h HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Modifier; Negative symptoms; Sequential addition

Indexed keywords

DYSBINDIN; MESSENGER RNA;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77349091592     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31029     Document Type: Article

References (50)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7):827-834.
2. Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ, Kahn RS. 2004. Neuregulin 1: Genetic support for schizophrenia subtypes. Mol Psychiatry 9:1061-1063.
3. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. 2001. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241.
4. Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, Kucherlapati R, Malhotra AK. 2006. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet 15:1563-1568.
5. Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, Malhotra AK. 2007. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res 89:169-172.
6. Chen Q, Wang X, O'Neill FA, Walsh D, Fanous A, Kendler KS, Chen X. 2008. Association study of CSF2RB with schizophrenia in Irish family and case-control samples. Mol Psychiatry 13(10):930-938.
7. Chiba S, Hashimoto R, Hattori S, Yohda M, Lipska B, Weinberger DR, Kunugi H. 2006. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 113:1337-1346.
8. Corvin A, Donohoe G, Nangle JM, Schwaiger S, Morris D, Gill M. 2008. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci Lett 431:146-149.
9. Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, Lawrence J, Pimm J, Bass N, Lamb G, Moorey H, Morgan J, Punukollu B, Kandasami G, Kirwin S, Sule A, Quested D, Curtis D, Gurling HM. 2007. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behav Brain Funct 3:50.
10. Dell'Angelica EC. 2004. The building BLOC(k)s of lysosomes and related organelles. Curr Opin Cell Biol 16:458-464.
11. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, Kucherlapati R, Malhotra AK. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163:532-534.
12. Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, Nangle JM, Garavan H, Robertson IH, Gill M, Corvin A. 2007. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia 45:454-458.
13. Duan J, Martinez M, Sanders AR, Hou C, Burrell GJ, Krasner AJ, Schwartz DB, Gejman PV. 2007. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: Association evidence in the 3' end of the gene. Hum Hered 64:97-106.
14. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121.
15. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, Pulver AE. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77:918-936.
16. Fanous AH, van den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, Walsh D, Kendler KS. 2005. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162:1824-1832.
17. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, Kucherlapati R, Malhotra AK. 2004. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 75:891-898.
18. Hall D, Gogos JA, Karayiorgou M. 2004. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 3:240-248.
19. Holliday EG, Handoko HY, James MR, McGrath JJ, Nertney DA, Tirupati S, Thara R, Levinson DF, Hayward NK, Mowry BJ, Nyholt DR. 2006. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res Hum Genet 9:531-539.
20. Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS. 2006. The dysbindin gene (DTNBP1) and schizophrenia: No support for an association in the Korean population. Neurosci Lett 407:101-106.
21. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R, Koleva S, Dimitrova A, Toncheva D, O'Donovan MC, Owen MJ. 2004. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 55:971-975.
22. Li T, Zhang F, Liu X, Sun X, Sham PC, Crombie C, Ma X, Wang Q, Meng H, Deng W, Yates P, Hu X, Walker N, Murray RM, St. Clair D, Collier DA. 2005. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry 10:1037-1044.
23. Liu CM, Liu YL, Fann CS, Yang WC, Wu JY, Hung SI, Chen WJ, Chueh CM, Liu WM, Liu CC, Hsieh MH, Hwang TJ, Faraone SV, Tsuang MT, Hwu HG. 2007. No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families. Schizophr Res 93:391-398.
24. Luciano M, Miyajima F, Lind PA, Bates TC, Horan M, Harris SE, Wright MJ, Ollier WE, Hayward C, Pendleton N, Gow AJ, Visscher PM, Starr JM, Deary IJ, Martin NG, Payton A. 2009. Variation in the dysbindin gene and normal cognitive function in three independent population samples. Genes Brain Behav 8:218-227.
25. Macgregor S, Craddock N, Holmans PA. 2006. Use of phenotypic covariates in association analysis by sequential addition of cases. Eur J Hum Genet 14:529-534.
26. Maher BS, Reimers MA, Riley BP, Kendler KS. Allelic heterogeneity in genetic association meta-analysis: An application to DTNBP1 and schizophrenia. In press, Human Heredity.
27. Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP. 2003. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 60:167-172.
28. Muthen LK, Muthen BO. 2001. Mplus: Statistical Analysis with Latent Variables: User's Guide. Los Angeles: Muthen and Muthen.
29. Mutsuddi M, Morris DW, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. 2006. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am J Hum Genet 79:903-909.
30. Pedrosa E, Ye K, Nolan KA, Morrell L, Okun JM, Persky AD, Saito T, Lachman HM. 2007. Positive association of schizophrenia to JARID2 gene. Am J Med Genet Part B 144B:45-51.
31. Riley BP, Kuo PH, Maher BS, Fanous AH, Sun J, Wormley BK, O'Neill FA, Walsh D, Zhao Z, Kendler KS. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Submitted to Schizophrenia Research.
32. SAS Institute Inc. SAS software version 9.1.3. 2005. Cary, NC. Ref Type: Computer Program.
33. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB. 2003. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72:185-190.
34. Spitzer RL, Williams JBW. 1985. Structured clinical interview for DSM-III-R (SCID). New York: Biometrics Research Department, New York State Psychiatric Institute.
35. Stahl SM, Buckley PF. 2007. Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatr Scand 115:4-11.
36. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337-348.
37. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187-1192.
38. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. 2008. Candidate genes for schizophrenia: A survey of association studies and gene ranking. Am J Med Genet Part B 147B(7):1173-1181.
39. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. 2004. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113:1353-1363.
40. Tochigi M, Zhang X, Ohashi J, Hibino H, Otowa T, Rogers M, Kato T, Okazaki Y, Kato N, Tokunaga K, Sasaki T. 2006. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 56:154-158.
41. Tosato S, Ruggeri M, Bonetto C, Bertani M, Marrella G, Lasalvia A, Cristofalo D, Aprili G, Tansella M, Dazzan P, Diforti M, Murray RM, Collier DA. 2007. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet Part B 144B:647-659.
42. Turunen JA, Peltonen JO, Pietilainen OP, Hennah W, Loukola A, Paunio T, Silander K, Ekelund J, Varilo T, Partonen T, Lonnqvist J, Peltonen L. 2007. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res 91:27-36.
43. van den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X. 2003a. FP-TDI SNP scoring by manual and statistical procedures: A study of error rates and types. Biotechniques 34:610-620, 622.
44. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, Riley BP. 2003b. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of highdensity schizophrenia families. Mol Psychiatry 8:499-510.
45. Vilella E, Costas J, Sanjuan J, Guitart M, DeDiego Y, Carracedo A, Martorell L, Valero J, Labad A, De Frutos R, Najera C, Molto MD, Toirac I, Guillamat R, Brunet A, Valles V, Perez L, Leon M, de Fonseca FR, Phillips C, Torres M. 2008. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 42:278-288.
46. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. 2004. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61: 544-555.
47. Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. 2008. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 98:105-110.
48. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, Norton N, Williams H, Clement M, Dwyer S, Curran C, Wilkinson J, Moskvina V, Waddington JL, Gill M, Corvin AP, Zammit S, Kirov G, Owen MJ, O'Donovan MC. 2004. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 61:336-344.
49. Wood LS, Pickering EH, Dechairo BM. 2007. Significant support for DAO as a schizophrenia susceptibility locus: Examination of five genes putatively associated with schizophrenia. Biol Psychiatry 61:1195-1199.
50. Zinkstok JR, de Wilde O, van Amelsvoort TA, Tanck MW, Baas F, Linszen DH. 2007. Association between the DTNBP1 gene and intelligence: A case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behav Brain Funct 3:19.